search
Back to results

Exercise in Breast Cancer Survivors

Primary Purpose

Breast Cancer, Obesity

Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise
Sponsored by
University of Mississippi Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Breast Cancer focused on measuring Breast Cancer, Obesity, Exercise, Angiogenesis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • > 18 years of age and < 65 years of age
  • Female
  • BMI > 25
  • Weight < 350 pounds
  • English as a primary language
  • Postmenopausal
  • Invasive ER-positive cancer on biopsy and subsequent definitive surgical therapy
  • Received and Completed standard of care adjuvant therapy (Concurrent endocrine therapy acceptable)
  • 6-12 months after completion of therapy (excluding adjuvant endocrine therapy) at time of randomization

Exclusion Criteria:

  • Recurrent breast cancer
  • DCIS only (no invasive component)
  • Taking a Beta Blocker or Verapamil
  • Pregnant
  • Wheelchair bound
  • Unable to ambulate independently
  • Concurrent uncontrolled medical or psychiatric disorder
  • Open wound
  • Stage IV breast cancer
  • Progression of disease
  • Bilateral mastectomies

Sites / Locations

  • University of Mississippi Health Care

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Exercise Group

No Exercise

Arm Description

The intervention is a structured walking program which will be performed partly in the Pavilion Physical Therapy clinic and partly at home. The participant will be instructed in how hard to exercise, how long to exercise, and how many times in a week to exercise. You will also be instructed in how to exercise safely.

These participants will receive standard of care follow up.

Outcomes

Primary Outcome Measures

Number of participants that complete the study as a measure of feasibility of an exercise intervention in obese breast cancer survivors.
Number of participants that enroll in the study and actually complete the study

Secondary Outcome Measures

IGF-1, endostatin, and VEGF levels in obese breast cancer survivors undergoing an exercise intervention as a measure of angiostatic phenotype:
IFG-1 levels,unbound VEGF levels, Endostatin levels
Amount of adipose tissue mass as measured on CT scans in obese breast cancer survivors before and after exercise intervention as a measure of weight loss
Adipose tissue mass volume as measured on CT scan

Full Information

First Posted
April 2, 2012
Last Updated
December 1, 2014
Sponsor
University of Mississippi Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT01582685
Brief Title
Exercise in Breast Cancer Survivors
Official Title
Exercise in Breast Cancer Survivors: Analysis of Angiogenic Profile
Study Type
Interventional

2. Study Status

Record Verification Date
December 2014
Overall Recruitment Status
Withdrawn
Why Stopped
no patients enrolled
Study Start Date
April 2012 (undefined)
Primary Completion Date
June 2014 (Actual)
Study Completion Date
June 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Mississippi Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators hypothesize that exercise in postmenopausal breast cancer survivors will result in an increase in the plasma concentrations of angiostatic factors and a decrease in the plasma concentrations of angiogenic factors. Exercise is expected to result in a circulating angiostatic phenotype that inhibits adipose tissue mass, growth of breast cancer tumor, growth of microscopic residual disease after breast cancer resection, decreases rates of local-regional recurrence, decreases rates of distant recurrence, and increases survival.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Obesity
Keywords
Breast Cancer, Obesity, Exercise, Angiogenesis

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Exercise Group
Arm Type
Experimental
Arm Description
The intervention is a structured walking program which will be performed partly in the Pavilion Physical Therapy clinic and partly at home. The participant will be instructed in how hard to exercise, how long to exercise, and how many times in a week to exercise. You will also be instructed in how to exercise safely.
Arm Title
No Exercise
Arm Type
No Intervention
Arm Description
These participants will receive standard of care follow up.
Intervention Type
Behavioral
Intervention Name(s)
Exercise
Intervention Description
The participant will exercise for 16 weeks under supervision. The exercise regimen is increased slowly over 16 weeks.
Primary Outcome Measure Information:
Title
Number of participants that complete the study as a measure of feasibility of an exercise intervention in obese breast cancer survivors.
Description
Number of participants that enroll in the study and actually complete the study
Time Frame
12 months
Secondary Outcome Measure Information:
Title
IGF-1, endostatin, and VEGF levels in obese breast cancer survivors undergoing an exercise intervention as a measure of angiostatic phenotype:
Description
IFG-1 levels,unbound VEGF levels, Endostatin levels
Time Frame
12 months
Title
Amount of adipose tissue mass as measured on CT scans in obese breast cancer survivors before and after exercise intervention as a measure of weight loss
Description
Adipose tissue mass volume as measured on CT scan
Time Frame
12 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: > 18 years of age and < 65 years of age Female BMI > 25 Weight < 350 pounds English as a primary language Postmenopausal Invasive ER-positive cancer on biopsy and subsequent definitive surgical therapy Received and Completed standard of care adjuvant therapy (Concurrent endocrine therapy acceptable) 6-12 months after completion of therapy (excluding adjuvant endocrine therapy) at time of randomization Exclusion Criteria: Recurrent breast cancer DCIS only (no invasive component) Taking a Beta Blocker or Verapamil Pregnant Wheelchair bound Unable to ambulate independently Concurrent uncontrolled medical or psychiatric disorder Open wound Stage IV breast cancer Progression of disease Bilateral mastectomies
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Natale Sheehan, MD
Organizational Affiliation
University of Mississippi Health Care
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Mississippi Health Care
City
Jackson
State/Province
Mississippi
ZIP/Postal Code
39216
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Exercise in Breast Cancer Survivors

We'll reach out to this number within 24 hrs